Key Market Indicators
Sales of digestive system disorder medicines in Ireland are expected to reach $224 million by 2026. This is a 2% decline from the 2021 figure of $252.1 million. Since 2013, the Irish market has grown by 1.6% each year. In 2021, Ireland was ranked 22nd, with Hungary in first place at $252.1 million. Japan, South Korea and Canada followed in second, third and fourth place, respectively.
